1425-10-1

Basic information

• Product Name: 19-NORTESTOSTERONE ACETATE
• Synonyms: Estr-4-en-3-one, 17-(acetyloxy)-, (17beta)- (9ci);Nsc 73213;NANDROLONE ACETATE;19-NORTESTOSTERONE ACETATE;4-ESTREN-17-BETA-OL-3-ONE ACETATE;4-ESTREN-17BETA-OL-3-ONE 17-ACETATE;17beta-hydroxyestr-4-en-3-one 17-acetate;17β-Acetoxyestra-4-ene-3-one
• CAS NO: 1425-10-1
• Molecular Formula: C₂₀H₂₈O₃
• Molecular Weight: 316.43
• EINECS: 215-842-6
• Mol File: 1425-10-1.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 441.2°Cat760mmHg
• Flash Point: 192.4°C
• Appearance: /
• Density: 1.13g/cm³
• CAS DataBase Reference: 19-NORTESTOSTERONE ACETATE(CAS DataBase Reference)
• NIST Chemistry Reference: 19-NORTESTOSTERONE ACETATE(1425-10-1)
• EPA Substance Registry System: 19-NORTESTOSTERONE ACETATE(1425-10-1)

Safety Data

• Hazardous Substances Data: 1425-10-1(Hazardous Substances Data)

Usage

General Description

19-Nortestosterone acetate, also known as nandrolone, is a synthetic anabolic steroid that is derived from testosterone. It is commonly used in both veterinary and clinical settings for its anabolic effects, including promoting muscle growth and enhancing athletic performance. Nandrolone acetate is a modified form of the hormone testosterone and is known for its ability to increase the production of red blood cells, as well as its potential to improve bone density and stimulate appetite. However, like other anabolic steroids, it is associated with potential side effects and risks, including cardiovascular complications, liver damage, and hormonal imbalances. Therefore, it should only be used under the supervision of a qualified healthcare professional.

Upstream product

• 6678-08-6 17β,19-dihydroxyandrost-4-en-3-one 17-acetate 
• 1758-20-9 17β,19-dihydroxy-androst-4-en-3-one 17,19-diacetate 
• 4999-76-2 3,17β-diacetoxyoestra-3,5-diene 
• 7082-72-6 3,19-Dioxo-17β-acetoxy-Δ⁴-androsten 
• 2590-41-2 6-dehydro-19-nortestosterone acetate 
• 762-72-1 allyl-trimethyl-silane 
• 434-22-0 19-nortestosterone 
• 108-24-7 acetic anhydride 
• 1091-93-6 3-methoxy-17-hydroxyestra-2,5⁽¹⁰⁾-diene 

Downstream Products

• 1743-60-8 17-β-estradiol 17-acetate 
• 18367-54-9 3,3-(ethylenedioxy)-5(10)-estren-17β-yl acetate 
• 1092-04-2 2α-Methyl-19-nor-testosteron 
• 3919-20-8 2β-Methyl-17β-hydroxy-oestr-4-en-3-on 
• 23463-05-0 estra-1,3,5(10)-triene-2,3,17β-triol-17-acetate 
• 362-05-0 2-Hydroxyestradiol 
• 6197-94-0 17β-acetoxy-5-oxo-3,5-seco-A-nor-estran-3-oic acid 
• 1164-99-4 17β-acetoxy-4-chloro-estr-4-en-3-one 
• 19793-20-5 19-nor-androst-4-ene-3β,17β-diol 
• 35950-87-9 Estren 
• 2590-41-2 6-dehydro-19-nortestosterone acetate 
• 13209-45-5 estra-4,6-diene-3,17-dione 
• 14531-84-1 17β-hydroxyestra-4,6-dien-3-one 
• 474-86-2 equilin 

Relevant articles and documents

On the photochemistry of alpha, beta-unsaturated gamma-aldehydoketones. I. The UVirradiation of 3, 19-dioxo-17-beta-acetoxy-delta-4-androstene

-

19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF

Provided herein are 19-nor C3,3-disubstituted C21-pyrazolyl steroids of Formula (I), and pharmaceutically acceptable salts thereof; wherein-, R1, R2, R3a, R3b, R4a, R4b, R5, R6, and R7are as defined herein. Such compounds are contemplated useful for the prevention and treatment of a variety of CNS-related conditions, for example, treatment of sleep disorders, mood disorders, schizophrenia spectrum disorders, convulsive disorders, disorders of memory and/or cognition, movement disorders, personality disorders, autism spectrum disorders, pain, traumatic brain injury, vascular diseases, substance abuse disorders and/or withdrawal syndromes, and tinnitus.

The Preparation of 7α- and 7β-Allyloestradiol, and an Unusual Titanium(IV) Chloride Mediated Dimerisation

17β-Acetoxyoestra-4,6-dien-3-one reacts with allyltrimethylsilane in the presence of fluoride ion to give the 7α- and 7β-allyloestr-4-en-3-ones in low yield.With titanium(IV) chloride catalysis, the 7α-allyloestr-4-en-3-one is the only product at -78 deg C, but its novel 6β,6'β-'dimer' is also formed at higher temperatures.The isomeric 7-allyloestr-4-en-3-ones have been aromatised to give 7α- and 7β-allyloestradiols.